SPAP-article-iqone-celltrion

iQone Healthcare Switzerland Supports Cancer Patients Through SPAP Partnership

iQone Healthcare Switzerland (a Celltrion company) is proud to have joined the Swiss Patient Access Program (SPAP).

biosimilars feature image

Everything You Need to Know About Biosimilars

In recent years, the healthcare sector has seen a significant increase in the adoption of biosimilar drugs.

Intro biologica image

From Breakthrough to Everyday Treatment: Biologics Revolutionizing Inflammatory Disease Management

Inflammatory diseases (ID) like rheumatoid arthritis, Crohn's disease, and ulcerative colitis have long been a challenge to manage and treat.

latest news & articles